Education
About Us
Working with TipRanks
Follow Us
Kevin Lee Insider Profile
4 Followers
Kevin Lee, CEO, Director at Bicycle Therapeutics, holds 480.80K shares in Bicycle Therapeutics (Ticker: BCYC). Most recently, Kevin Lee Sold $5,461 shares of Bicycle Therapeutics on Jul 07, 2025 for an estimated value of 39.84K.
Profitable Transactions
7 out of 11 Profitable Transactions
Average Return
+22.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Kevin Lee holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Apr 05, 2024 - Apr 05, 2025
Return:+69.60%
The most profitable trade made by Kevin Lee
Kevin Lee's Trading History
List of latest transactions for each holding click on a transaction to see Kevin Lee's performance on stock
You May Also Like
Kevin Lee insider profile FAQ
What is the percentage of profitable transactions made by Kevin Lee?
The percentage of profitable transactions made by Kevin Lee is 64%.
What is the average return per transaction made by Kevin Lee?
The average return per transaction made by Kevin Lee is 22.80%.
What stocks does Kevin Lee hold?
Kevin Lee holds: BCYC stocks.
What was Kevin Lee’s latest transaction?
Kevin Lee latest transaction was an Informative Sell of $39.84K.
What was Kevin Lee's most profitable transaction?
Kevin Lee’s most profitable transaction was an Informative Sell of BCYC stock on April 5, 2024. The return on the trade was 69.60%.
What is Kevin Lee's role in Bicycle Therapeutics?
Kevin Lee's role in Bicycle Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.